Sign In
Buy MMEDF
$1.09
+0 (+0%)
At Close: Aug 17, 2022
MindMed Reveals Results Of A Study On Personalized MDMA Dosing
01:17pm, Monday, 05'th Apr 2021
Psychedelic medicine biotech company MindMed (NEO: MMED) (OTCQB:MMEDF) (DE: MMQ) reported Monday the results of a study on MDMA dosing optimization utilizing personalized medicine. The study was condu
MindMed says new study data highlights effectiveness of personalized MDMA dosing regime
10:09am, Monday, 05'th Apr 2021
Mind Medicine (MindMed) Inc (NEO:MMED) (OTCQB:MMEDF) (FRA:MMQ) published new data from its MDMA study on Monday that revealed the dosage can be optimized based on known predictors like a person's age
MindMed Announces the Publication of New Data on Personalized MDMA Dosing
07:30am, Monday, 05'th Apr 2021
BASEL, Switzerland, April 5, 2021 /PRNewswire/ -- MindMed (NEO: MMED) (OTCQB: MMEDF) (DE: MMQ), a leading clinical-stage psychedelic medicine biotech company, announced the publication of the first s
Best Sin Stocks in 2021
05:01pm, Thursday, 01'st Apr 2021
Investing in sin stocks is, admittedly, a cynical strategy. But there's a reason investors keep returning to them.
MMEDF Stock: Why Psychedelics Play MindMed Is Rocketing Higher
05:09pm, Wednesday, 31'st Mar 2021
Preliminary registration filings in Canada and the U.S. are more good news on top of full year 2020 earnings results for MindMed and MMEDF stock. The post MMEDF Stock: Why Psychedelics Play MindMed Is
MindMed Announces Filing of Preliminary Base Shelf Prospectus and F-10 with the SEC under MJDS
05:32pm, Tuesday, 30'th Mar 2021
TORONTO, March 30, 2021 /PRNewswire/ -- Mind Medicine (MindMed) Inc. ("MindMed" or the "Company") (NEO: MMED), (OTCQB: MMEDF), (DE: MMQ) is pleased to announce that it has filed a new preliminary sh
MindMed has strong cash balance of US$161M to advance its drug development pipeline
10:11am, Tuesday, 30'th Mar 2021
Mind Medicine (MindMed) Inc (NEO:MMED) (OTCQB:MMEDF) (FRA:MMQ) posted 2020 year-end financial results with ample funds to support its drug development pipeline and creation of its psychedelic medicin
Net Cash Used in Operating Activities (Total Cash Burn) of $24.2 million USD ($30.5 million CAD) for year ended December 31, 2020 NEW YORK, March 30, 2021 /PRNewswire/ -- Mind Medicine (MindMed) Inc.
MindMed appoints Stanford University neuroscientist as chair of scientific advisory board
08:49am, Monday, 29'th Mar 2021
Mind Medicine Inc (MindMed) (NEO:MMED), (OTCQB:MMEDF), (FRA:MMQ) said it has appointed Robert C. Malenka, an accomplished neuroscientist and psychiatry professor from Stanford University, to chair its
MindMed Announces the Addition of Stanford University Neuroscientist as Chair of the Scientific Advisory Board
07:30am, Monday, 29'th Mar 2021
Dr. Robert C. Malenka is the Pritzker Professor of Psychiatry and Behavioral Sciences, Director of the Nancy Pritzker Laboratory and Deputy Director of the Wu Tsai Neurosciences Institute at Stanford
Psychedelic Therapeutics Company Mind Medicine Added to FTSE Indexes
09:36pm, Monday, 22'nd Mar 2021
The stock will be listed on both the FTSE Global Micro Cap and the FTSE Total Cap Indexes.
MindMed Best In Psychedelic Space, Could Still Be In 'Third Inning': Kevin O'Leary
08:27am, Sunday, 21'st Mar 2021
Jason Raznick, the founder and CEO of Benzinga interviewed Kevin O'Leary on the “Raz Report” last week. Among the topics discussed was O'Leary's stake in Mind Medicine Inc (OTC: MMEDF).
7 Sin Stocks That Are Living the Good Life
12:13pm, Monday, 08'th Mar 2021
With the markets still uncertain, it's time to get cynical and consider entering one of these bad-boy names. Here are seven sin stocks to buy.
Mind Medicine: Much Needed Novelty With Inherent Risks And Bubbly Right Now
10:54am, Monday, 08'th Mar 2021
MindMed is targeting intriguing psychiatric issues with lucrative markets such as opioid addiction, anxiety, ADHD and cluster headaches. Recent partnerships and acquisitions seem promising and bring c
MindMed closes on acquisition of digital medicine company HealthMode
02:48pm, Friday, 26'th Feb 2021
Mind Medicine (MindMed) Inc (NEO:MMED) (OTCQB:MMEDF) (FRA:MMQ) has closed on its acquisition of HealthMode, a digital medicine and therapeutics startup that uses Artificial Intelligence (AI)-enabled
